These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3293092)

  • 1. Effect of naloxone on acute stroke.
    Czlonkowska A; Cyrta B
    Pharmacopsychiatry; 1988 Mar; 21(2):98-100. PubMed ID: 3293092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piracetam in the treatment of acute stroke.
    Orgogozo JM
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():25-32. PubMed ID: 10338105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naftidrofuryl in the treatment of subacute stroke.
    Capon A; Lehert P; Opsomer L
    J Cardiovasc Pharmacol; 1990; 16 Suppl 3():S62-6. PubMed ID: 1369722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A double blind randomized pilot trial of naloxone in the treatment of acute ischemic stroke.
    Federico F; Lucivero V; Lamberti P; Fiore A; Conte C
    Ital J Neurol Sci; 1991 Dec; 12(6):557-63. PubMed ID: 1783533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Randomized double-blind study of flunarizine versus placebo in patients with chronic cerebrovascular disorders.
    Agnoli A; Manna V; Martucci N; Fioravanti M; Ferromilone F; Cananzi A; D'Andrea G; De Rosa A; Vizioli R; Sinforiani E
    Int J Clin Pharmacol Res; 1988; 8(3):189-97. PubMed ID: 3042644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double blind trial of naloxone in the treatment of acute stroke.
    Fallis RJ; Fisher M; Lobo RA
    Stroke; 1984; 15(4):627-9. PubMed ID: 6087500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter trial of naloxone in Alzheimer's disease.
    Henderson VW; Roberts E; Wimer C; Bardolph EL; Chui HC; Damasio AR; Eslinger PJ; Folstein MF; Schneider LS; Teng EL
    Ann Neurol; 1989 Apr; 25(4):404-6. PubMed ID: 2653175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of the clinical effects of vincamine + glycerol versus glycerol + placebo in the acute phase of stroke.
    Dekoninck WJ; Jocquet P; Jacquy J; Henriet M
    Arzneimittelforschung; 1978; 28(9):1654-7. PubMed ID: 383107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical safety of high-dose piracetam--its use in the treatment of acute stroke.
    De Reuck J; Van Vleymen B
    Pharmacopsychiatry; 1999 Mar; 32 Suppl 1():33-7. PubMed ID: 10338106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indication of an antipsychotic action of the opiate antagonist naloxone.
    Emrich HM; Cording C; Pirée S; Kölling A; von Zerssen D; Herz A
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Sep; 10(5):265-70. PubMed ID: 30101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low- and high-dose naloxone in dementia of the Alzheimer type.
    Tariot PN; Sunderland T; Weingartner H; Murphy DL; Cohen MR; Cohen RM
    Psychopharmacol Bull; 1985; 21(3):680-2. PubMed ID: 3898183
    [No Abstract]   [Full Text] [Related]  

  • 12. Effectiveness of high dose dexamethasone in the treatment of acute stroke.
    Ogun SA; Odusote KA
    West Afr J Med; 2001; 20(1):1-6. PubMed ID: 11505880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical evaluation of GABA in the treatment of cerebrovascular disorders. Multi-center double-blind study in comparison with pyrithioxine and placebo.
    Otomo E; Araki G; Mori A; Kurihara M
    Arzneimittelforschung; 1981; 31(9):1511-23. PubMed ID: 7030354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of dexamethasone in the outcome from acute stroke.
    Kumar N; Jain S; Maheshwari MC
    J Assoc Physicians India; 1989 May; 37(5):315-7. PubMed ID: 2693439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind placebo-controlled trial of naloxone on motor deficits in acute cerebrovascular disease.
    Perraro F; Tosolini G; Pertoldi F; Sbrojavacca R; Beorchia A; Bulfoni A; Del Fabbro L; Grassi L; Lestuzzi A; Mione V
    Lancet; 1984 Apr; 1(8382):915. PubMed ID: 6143225
    [No Abstract]   [Full Text] [Related]  

  • 16. Comparative study of tilidine-naloxone and pentazocine in knee and hip osteoarthritis.
    Van Cauwenberge H; Ruhwiedel M; Albert A; Franchimont P
    Int J Clin Pharmacol Res; 1992; 12(1):1-9. PubMed ID: 1526693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A double-blind controlled clinical study on the use of mucopolysaccharides in the treatment of patients with cerebral vasculopathy. Comparison with a placebo].
    Bardin P; Campo R
    Clin Ter; 1987 Jan; 120(2):111-8. PubMed ID: 2972439
    [No Abstract]   [Full Text] [Related]  

  • 18. The objective measurement of mental performance in cerebrovascular disease. A double-blind controlled study, using a graded-release preparation of isoxsuprine.
    Hussain SM; Gedye JL; Naylor R; Brown AL
    Practitioner; 1976 Feb; 216(1292):222-8. PubMed ID: 772660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical double blind study with the calcium antagonist flunarizine cerebral circulatory disturbances].
    Eckmann F
    Arzneimittelforschung; 1985; 35(8):1276-9. PubMed ID: 3907638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenously administered acetylsalicylic acid in combination with low-dose heparin in acute ischemic stroke: a safety analysis.
    Büttner T; Hellwig K; Müller T; Kuhn W
    Clin Neuropharmacol; 1998; 21(1):48-51. PubMed ID: 9579285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.